insurance changes to glp 1 drugs Major are coming GLP-1 for weight loss. Here's how that could affect patients States cutting back on coverage
Description
The compounding industry disagrees

Thyroid C-Cell Tumors: In mice and rats, semaglutide (the active ingredient in Wegovy, Ozempic, and Rybelsus) caused an increase in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)

In conclusion, GLP-1 agonists are a promising treatment option for weight loss in PCOS patients

About the Author : Carrie Forrest has a masters degree in public health with a specialty in nutrition and is a certified holistic nutritionist
Ketogenic diets may pose risks to people with certain health conditions.* Adherence is an issue,* as well, with many people finding the diet difficult and unrealistic to sustain over a long time

J Clin Invest 101(7):14211430